Works matching IS 00192805 AND DT 2022 AND VI 166 AND IP 1
Results: 12
Annexin‐A1: The culprit or the solution?
- Published in:
- Immunology, 2022, v. 166, n. 1, p. 2, doi. 10.1111/imm.13455
- By:
- Publication type:
- Article
Featured Cover.
- Published in:
- Immunology, 2022, v. 166, n. 1, p. i, doi. 10.1111/imm.13484
- Publication type:
- Article
The roles of interleukin‐1 receptor accessory protein in certain inflammatory conditions.
- Published in:
- Immunology, 2022, v. 166, n. 1, p. 38, doi. 10.1111/imm.13462
- By:
- Publication type:
- Article
HLA‐dependent variation in SARS‐CoV‐2 CD8 <sup>+</sup> T cell cross‐reactivity with human coronaviruses.
- Published in:
- Immunology, 2022, v. 166, n. 1, p. 78, doi. 10.1111/imm.13451
- By:
- Publication type:
- Article
Distinguishing activated T regulatory cell and T conventional cells by single‐cell technologies.
- Published in:
- Immunology, 2022, v. 166, n. 1, p. 121, doi. 10.1111/imm.13460
- By:
- Publication type:
- Article
Effector immune cells in chronic lung allograft dysfunction: A systematic review.
- Published in:
- Immunology, 2022, v. 166, n. 1, p. 17, doi. 10.1111/imm.13458
- By:
- Publication type:
- Article
Editorial: Diverse responses to SARS‐CoV‐2 in the human population.
- Published in:
- Immunology, 2022, v. 166, n. 1, p. 1, doi. 10.1111/imm.13478
- Publication type:
- Article
Oncolytic virus treatment differentially affects the CD56<sup>dim</sup> and CD56<sup>bright</sup> NK cell subsets in vivo and regulates a spectrum of human NK cell activity.
- Published in:
- Immunology, 2022, v. 166, n. 1, p. 104, doi. 10.1111/imm.13453
- By:
- Publication type:
- Article
Macrophage metabolism in the intestine is compartment specific and regulated by the microbiota.
- Published in:
- Immunology, 2022, v. 166, n. 1, p. 138, doi. 10.1111/imm.13461
- By:
- Publication type:
- Article
HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19.
- Published in:
- Immunology, 2022, v. 166, n. 1, p. 68, doi. 10.1111/imm.13450
- By:
- Publication type:
- Article
Staphylococcus aureus controls eicosanoid and specialized pro‐resolving mediator production via lipoteichoic acid.
- Published in:
- Immunology, 2022, v. 166, n. 1, p. 47, doi. 10.1111/imm.13449
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Immunology, 2022, v. 166, n. 1, p. ii, doi. 10.1111/imm.13356
- Publication type:
- Article